JP2007536359A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007536359A5 JP2007536359A5 JP2007512321A JP2007512321A JP2007536359A5 JP 2007536359 A5 JP2007536359 A5 JP 2007536359A5 JP 2007512321 A JP2007512321 A JP 2007512321A JP 2007512321 A JP2007512321 A JP 2007512321A JP 2007536359 A5 JP2007536359 A5 JP 2007536359A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- ltb
- biosynthesis
- function
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003112 inhibitor Substances 0.000 claims 14
- 239000003814 drug Substances 0.000 claims 9
- 230000015572 biosynthetic process Effects 0.000 claims 8
- 229940124597 therapeutic agent Drugs 0.000 claims 6
- 239000002246 antineoplastic agent Substances 0.000 claims 5
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 4
- 208000003950 B-cell lymphoma Diseases 0.000 claims 4
- 208000032568 B-cell prolymphocytic leukaemia Diseases 0.000 claims 4
- 230000007246 mechanism Effects 0.000 claims 2
- 101100236208 Homo sapiens LTB4R gene Proteins 0.000 claims 1
- 102100033374 Leukotriene B4 receptor 1 Human genes 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000010534 mechanism of action Effects 0.000 claims 1
- CEUDWZXMLMKPNN-SOFGYWHQSA-N n-hydroxy-n-[(e)-3-(3-phenoxyphenyl)prop-2-enyl]acetamide Chemical compound CC(=O)N(O)C\C=C\C1=CC=CC(OC=2C=CC=CC=2)=C1 CEUDWZXMLMKPNN-SOFGYWHQSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56826204P | 2004-05-06 | 2004-05-06 | |
| GBGB0410103.6A GB0410103D0 (en) | 2004-05-06 | 2004-05-06 | New method |
| PCT/GB2005/001724 WO2005107725A1 (en) | 2004-05-06 | 2005-05-05 | Use of ltb4 inhibitors for the treatment of b-cell leukemias and lymphomas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007536359A JP2007536359A (ja) | 2007-12-13 |
| JP2007536359A5 true JP2007536359A5 (https=) | 2008-06-26 |
Family
ID=32482771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007512321A Withdrawn JP2007536359A (ja) | 2004-05-06 | 2005-05-05 | Ｂ細胞の白血病及びリンパ腫の治療のためのｌｔｂ４インヒビターの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20080081835A1 (https=) |
| EP (1) | EP1742622A1 (https=) |
| JP (1) | JP2007536359A (https=) |
| GB (1) | GB0410103D0 (https=) |
| WO (1) | WO2005107725A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9732320B2 (en) | 2008-01-18 | 2017-08-15 | The Brigham And Women's Hospital, Inc. | Selective differentiation, identification, and modulation of human TH17 cells |
| WO2009092087A2 (en) * | 2008-01-18 | 2009-07-23 | The Brigham And Women's Hospital, Inc. | Selective differentiation, identification, and modulation of human th17 cells |
| JP2011519870A (ja) * | 2008-05-21 | 2011-07-14 | テイコク ファーマ ユーエスエー インコーポレーテッド | 非ステロイド性抗炎症薬の経皮投与による月経困難症の治療 |
| GB0810011D0 (en) * | 2008-06-02 | 2008-07-09 | Jackson William P | 5-Lipoxygenase inhibitors |
| NZ719169A (en) | 2013-12-20 | 2018-08-31 | Novartis Ag | Heteroaryl butanoic acid derivatives as lta4h inhibitors |
| CN115068486A (zh) * | 2021-03-15 | 2022-09-20 | 中国医学科学院药物研究所 | 乳香酸类化合物作为ltb4受体抑制剂的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU698313B2 (en) * | 1994-03-14 | 1998-10-29 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents |
| GB2290707A (en) * | 1994-06-28 | 1996-01-10 | Georgi Stankov | Pharmaceutical uses of Amphotericin B |
| DE60042338D1 (de) * | 1999-10-04 | 2009-07-16 | Univ New Jersey Med | TAR RNA bindende Peptide |
| WO2001034133A2 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| WO2001034134A2 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| AU1917101A (en) * | 1999-11-11 | 2001-06-06 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| AU1592901A (en) * | 1999-11-11 | 2001-06-06 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| KR100653017B1 (ko) * | 2002-02-08 | 2006-12-01 | 에프. 호프만-라 로슈 아게 | 골 손실의 치료 및 예방 방법 |
| JP2003252763A (ja) * | 2002-02-27 | 2003-09-10 | Yuichiro Kamikawa | 抗腫瘍剤 |
| US6962940B2 (en) * | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| WO2004099783A2 (en) * | 2003-05-06 | 2004-11-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4) |
-
2004
- 2004-05-06 GB GBGB0410103.6A patent/GB0410103D0/en not_active Ceased
-
2005
- 2005-05-05 EP EP05741939A patent/EP1742622A1/en active Pending
- 2005-05-05 WO PCT/GB2005/001724 patent/WO2005107725A1/en not_active Ceased
- 2005-05-05 US US11/579,474 patent/US20080081835A1/en not_active Abandoned
- 2005-05-05 JP JP2007512321A patent/JP2007536359A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008501705A5 (https=) | ||
| WO2008040534A3 (en) | Non-mucoadhesive film dosage forms | |
| AR051099A1 (es) | Combinaciones terapeuticas que comprenden inhibidor de poli(adp-ribosa)polimerasas | |
| WO2007075554A3 (en) | Combination of igfr inhibitor and anti-cancer agent | |
| WO2005046318A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders | |
| MY130803A (en) | New quinuclidine amide derivatives | |
| WO2005044178A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| WO2004045593A3 (en) | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy | |
| EA201000617A1 (ru) | Комбинация, включающая производные пурина и другие соединения, и ее применение для лечения воспалительных и обструктивных заболеваний дыхательных путей | |
| CA2530308A1 (en) | 5ht2c receptor agonists for the treatment of diabetes and obesity | |
| JP2008534453A5 (https=) | ||
| JP2006518731A5 (https=) | ||
| EP4442321A3 (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| JP2009513713A5 (https=) | ||
| AR060284A1 (es) | Terapia de combinacion de (2r,z)-2-amino-2-ciclohexil-n-(5-(1-metil-1h- pirazol- 4-il)-1- oxo- 2,6 dihidro-1h- [1,2] diazepino [4,5,6-cd] indol-8-il) acetamida | |
| JP2007536359A5 (https=) | ||
| NZ541187A (en) | Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) with an inhibitor of cytochrome P450, such as protease inhibitors | |
| CN101068549A (zh) | 与5－fu和5－fu前药组合施用dpd抑制剂的方法 | |
| WO2007064448A3 (en) | Cancer treatment using fts and 2-deoxyglucose | |
| ITMI20042475A1 (it) | Uso di derivati tiazolidinonici come agenti terapeutici | |
| SG160391A1 (en) | Cladribine regimen for treating multiple sclerosis | |
| JP2007525533A5 (https=) | ||
| WO2004037199A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| WO2010092436A1 (en) | Pharmaceutical combinations of simethicone and otilonium | |
| MXPA05009849A (es) | Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2. |